Role of c-myc Regulation in Zta-Mediated Induction of the Cyclin-Dependent Kinase Inhibitors p21 and p27 and Cell Growth Arrest  by Rodriguez, Antonio et al.
cVirology 284, 159–169 (2001)
doi:10.1006/viro.2001.0923, available online at http://www.idealibrary.com onRole of c-myc Regulation in Zta-Mediated Induction of the Cyclin-Dependent Kinase
Inhibitors p21 and p27 and Cell Growth Arrest
Antonio Rodriguez,1 Eun Joo Jung, Qinyan Yin, Corinne Cayrol,2 and Erik K. Flemington3
Department of Pathology, Tulane Cancer Center, Tulane University Health Sciences Center, New Orleans, Louisiana 70112
Received January 4, 2001; returned to author for revision March 5, 2001; accepted March 23, 2001
Latency-associated Epstein–Barr virus (EBV) gene expression induces cell proliferation. Unlike the latency associated
genes, lytic gene expression in EBV, as well as other herpesviruses, elicits cell cycle arrest. Previous studies have shown that
the EBV immediate early lytic transactivator, Zta, induces a G0/G1 cell cycle arrest through induction of the cyclin-dependent
kinase inhibitors, p21 and p27. Here we show that while EBV latency is intimately linked to activation of the protooncogene,
c-myc, Zta represses c-myc expression. We also show that inhibition of c-myc expression is required for Zta-mediated growth
arrest and for maximal induction of p21 and p27. Nevertheless, induction of p21 and p27 is also influenced by a c-myc-
independent mechanism. A detailed genetic analysis of Zta’s basic/DNA binding region identified two distinct subregions that
contribute to full induction of p21 and p27. One subdomain influences p21 and p27 expression through the c-myc-dependent
mechanism and the other subdomain influences p21 and p27 induction through the c-myc-independent pathway. Together,
these studies further our understanding of the complex nature of Zta-induced growth arrest. © 2001 Academic Press
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Herpesviruses are important pathogens in humans.
Both the human cytomegalovirus (CMV, a beta herpesvi-
rus) and the Epstein–Barr virus (EBV, a gamma herpes-
virus) are oncogenic viruses (Britt and Alford, 1996; Rick-
inson and Kieff, 1996). While oncogenic transformation
by CMV may occur through an abortive replication mech-
anism, the oncogenic potential of EBV lies largely in a set
of cell cycle promoting genes that are expressed during
latency (Kieff, 1996; Rickinson and Kieff, 1996). Expres-
sion of the latency-associated EBV immortalizing genes
likely plays a role in the viral life cycle by causing am-
plification and distribution of the infected B-cell popula-
tion during the early stages of host infection. Following
the development of an immune response to several of
these latency associated proteins, a significantly more
restricted pattern of latency gene expression arises and
persists in the host (Babcock et al., 1998, 1999; Miyashita
et al., 1997). In combination with other genetic events in
the host cell, however, this restricted form of latency
likely contributes to a variety of human cancers in immu-
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159nocompetent individuals including nasopharyngeal car-
cinoma, African Burkitt’s lymphoma, high-grade breast
cancer (Bonnet et al., 1999; Labrecque et al., 1995; Luq-
mani and Shousha, 1995), and some cases of gastric
carcinoma (Burke et al., 1990; Kieff, 1996; Rickinson and
Kieff, 1996; Shibata et al., 1991) .
Induction of the cellular oncogene, c-myc, is a crucial
step in the activation of cell cycle progression in both
epithelial and B-lymphocytes and c-myc is either in-
duced, amplified, and/or translocated in most epithelial
and B-lymphocyte tumors (Nesbit et al., 1999). c-myc is a
key downstream target of EBV latency-associated genes
in infected B-lymphocytes (Alfieri et al., 1991) and induc-
tion of c-myc expression by latency-associated genes
likely plays a crucial role in promoting cell cycle progres-
sion (Kaiser et al., 1999; Polack et al., 1996). Although
some latency-associated EBV genes can induce c-myc
expression, these genes are not expressed in EBV-as-
sociated tumors in immunocompetent individuals (Kaiser
et al., 1999). Instead, c-myc is translocated [Burkitt’s
lymphoma (Nesbit et al., 1999)], amplified [in some cases
of breast cancer (Nesbit et al., 1999)], or overexpressed
through some other mechanism [nasopharyngeal carci-
noma (Lin et al., 1993) and some cases of breast cancer
(Nesbit et al., 1999)].
Despite the clear association between herpesviruses
and human cancers, some early studies suggested that
productive infection/replication occurs in growth ar-
rested cells (de Bruyn and Knipe, 1988; Mocarski, 1996;
Roizman and Sears, 1996). Moreover, these studies, as
0042-6822/01 $35.00
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160 RODRIGUEZ ET AL.well as more recent studies (Bresnahan et al., 1996; de
Bruyn and Knipe, 1988; Dittmer and Mocarski, 1997; Eh-
mann et al., 2000; Hobbs and DeLuca, 1999; Lomonte
nd Everett, 1999; Lu and Shenk, 1996, 1999; Olgiate et
al., 1999; Salvant et al., 1998; Song et al., 2000; Wiebusch
nd Hagemeier, 1999), have demonstrated that during
roductive replication, herpes simplex virus (HSV, an
lpha herpesvirus) and CMV can actively block cell cycle
rogression. We have previously shown that the EBV-
ncoded immediate early transactivator, Zta, can elicit a
0/G1 cell cycle block in EBV positive and EBV negative
cells (Cayrol and Flemington, 1996a,b; Rodriguez et al.,
1999) and HSV and CMV encoded genes that block cell
cycle progression have recently been identified (Hobbs
and DeLuca, 1999; Lomonte and Everett, 1999; Lu and
Shenk, 1999). Evidence that blocking cell cycle progres-
sion is important for replication of EBV was shown by
Takase et al. (1996), who demonstrated that forcing cells
to progress into the S phase of the cell cycle inhibits EBV
replication.
Previous studies showed that Zta induces growth ar-
rest in part through induction of the cyclin-dependent
kinase inhibitors, p21 and p27 (Cayrol and Flemington,
1995, 1996a,b; Rodriguez et al., 1999). Induction of p21
and p27 was shown to occur at the RNA and posttran-
scriptional level, respectively (Cayrol and Flemington,
1996b). Reports from other groups have shown that in
certain settings, c-myc expression decreases the stabil-
ity of p27 (Muller et al., 1997; Nass and Dickson, 1998;
Perez-Roger et al., 1997). Further, it has been shown that
c-myc can down regulate p21 expression (Mitchell and
El-Diery, 1999). Based on these studies, we reasoned
that the continued presence of c-myc following Zta in-
duction would preclude up regulation of p21 and p27,
thus antagonizing Zta-mediated cell cycle arrest. We
therefore explored whether Zta has a means of regulat-
ing c-myc function and/or expression. We show here that
Zta down regulates c-myc function by inhibiting c-myc
RNA expression and that down regulation of c-myc is
required for Zta-mediated growth arrest (and for efficient
induction of p21 and p27). Genetic studies revealed that
an intact basic region is required for c-myc down regu-
lation. A genetic analysis of Zta’s basic/DNA binding
region identified two domains that mediate distinct c-
myc-dependent, and c-myc-independent, growth arrest
signaling. These studies indicate a multifaceted role of
Zta’s basic region in facilitating full growth arrest func-
tion.
RESULTS
Zta down regulates c-myc protein expression
Activation of the lytic cycle in vitro, through treatment
of EBV-infected cell lines with a wide variety of inducing
agents (including Zta) results in a G0/G1 growth arrest(Cayrol and Flemington, 1996a; Rodriguez et al., 2001).
Although EBV latency is associated with activated ex-
pression of the protooncogene, c-myc, induction of the
lytic cycle in the EBV positive nasopharyngeal cell line,
NPC-KT, results in decreased amounts of c-myc (Fig. 1A).
We have previously shown that the EBV immediate early
gene product, Zta, induces growth arrest, in part, through
induction of the cyclin-dependent kinase inhibitors, p21
and p27 (Cayrol and Flemington, 1996a) and others have
shown that p21 and p27 are regulated by c-myc (Mitchell
and El-Diery, 1999; Muller et al., 1997; Nass and Dickson,
1998; Perez-Roger et al., 1997). We therefore tested
whether Zta influences c-myc expression. As shown in
Fig. 1B, induction of Zta in two tetracycline-inducible EBV
negative cell lines, Hela and SAOS2, resulted in de-
creased amounts of c-myc protein. Northern blot analy-
sis revealed that Zta regulates c-myc expression at the
FIG. 1. (A) Down regulation of c-myc expression following treatment
of NPC-KT cells with the lytic cycle inducing agent, iodo deoxyuridine
(IDU). c-Myc protein levels were assessed utilizing the anti-c-Myc
antibody, C33 (Santa Cruz Biotech). (B) Expression of Zta in two tetra-
cycline inducible Zta cell lines, HeLa and SAOS2, elicits down regula-
tion of c-Myc. c-Myc protein levels were assessed as in A, and Zta was
detected using the M47 anti-Zta antibody (Rodriguez et al., 1999). (C)
Zta down regulates c-Myc at the RNA level. Hela–Zta and control cells
(Hela) were incubated in the presence or absence of tetracycline and
RNA levels of c-myc, E2F1, E2F3, and tubulin were assessed by con-
secutive probings of the indicated Northern blot.RNA level (Fig. 1C). Zta also down regulates expression
of the another cell cycle regulated transcription factor,
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161ROLE OF C-MYC IN ZTA-MEDIATED INDUCTION OF p21 AND p27E2F-1, although not as significantly as that observed with
c-myc. Zta had little effect on the expression of two other
cellular genes, E2F-3 and Tubulin (Fig. 1C).
Initial genetic analysis of Zta-mediated down
regulation of c-myc expression
We previously identified a series of Zta mutants that
defined important Zta-mediated growth arrest functions
(Rodriguez et al., 1999). A Zta point mutant that is defec-
ive for its ability to trigger the lytic cycle, Z(S186A) (Fran-
is et al., 1997), induces growth arrest and induces p21,
27, and p53 as effectively as wild-type Zta (Rodriguez et
l., 1999). As shown in Fig. 2, this mutant efficiently down
egulates c-myc expression. Deletion of Zta’s activation
omain completely abrogates its ability to activate re-
orter constructs but is only partially defective for its
rowth arrest functions (Rodriguez et al., 1999) [this par-
ial defect is likely due to a compromised ability to induce
27 (but not p21 or p53) (Rodriguez et al., 1999)]. As
hown in Fig. 2B, this mutant modulates the levels of
-myc but is not as effective as wild-type Zta. Finally,
lthough we have shown previously that DNA binding is
ot required for Zta-mediated growth arrest, replacement
f Zta’s basic/DNA binding domain with the analogous
egion of the Zta cellular homolog, c-fos, completely
FIG. 2. Genetic analysis of Zta-mediated c-myc down regulation. (A) S
the cellular homolog, c-Fos. (B) Initial genetic study of Zta-mediated gr
cell lines were generated previously (Rodriguez et al., 1999). Cell c
Rodriguez et al., 1999) and the results are summarized [111 5 86–87
et al., 1999)]. Zta expression was determined using the anti-Zta polyclo
anti-c-Myc monoclonal antibody, C33 (Santa Cruz Biotech). Results sh
results.brogates Zta’s ability to carry out this function (Rodri-
uez et al., 1999). This mutant, Z/Fos(basic) (Kolman etl., 1996), is expressed well (Fig. 2), is localized to the
ucleus (data not shown), and activates reporter plas-
ids containing AP1 promoter elements (Francis et al.,
997). In line with its inability to induce growth arrest,
/Fos(basic) is unable to down regulate c-myc expres-
ion (Fig. 2). Together, this limited genetic analysis sug-
ested a preliminary link between Zta-mediated growth
rrest and Zta-mediated down regulation of c-myc ex-
ression.
nforced expression of c-myc overrides Zta-mediated
rowth arrest and inhibits full induction of p21 and
27
To directly test whether Zta-mediated growth arrest
equires down regulation of c-myc, a Zta expression
ector was cotransfected with either a control vector or
ifferent amounts of a c-myc expression vector. As
hown in Fig. 3, expression of Zta alone elicits a G0/G1
growth arrest in HeLa and NPC-KT cells. In contrast,
cotransfection of a c-myc expression vector with a Zta
expression vector significantly inhibits Zta’s ability to
induce growth arrest in both cell lines. Interestingly,
while constitutive expression of c-myc inhibited the in-
duction of p21 and p27, it had no effect on Zta’s ability to
induce p53 expression. This indicates that while down
e of functional domains of Zta and alignment of the basic domain with
rrest and c-Myc down regulation. The indicated stable inducible Hela
alysis following tetracycline withdrawal was previously determined
70%, and 2 5 44% of cells in G0/G1 at 48 h postinduction (Rodriguez
ibody, M47 (Rodriguez et al., 1999) and c-Myc was analyzed using the
B have been repeated in transient transfection studies with similartructur
owth a
ycle an
%, 1 5
nal antregulation of c-myc likely plays a role in the induction of
p21 and p27, c-myc is either downstream or is indepen-
, anti-p
162 RODRIGUEZ ET AL.dent of p53 in Zta-mediated growth arrest. Notably, low-
level induction of p21 and p27 is observed at the higher
input amount of the Zta expression vector. This could
result from incomplete c-myc override of these Zta func-
tions. Alternatively, it is possible that other factors (path-
ways) also contribute to Zta-mediated induction of p21
and p27. Additional evidence shown below supports this
second model.
Genetic analysis of Zta’s basic/DNA-binding domain
in Zta-mediated growth arrest
To date, our studies addressing the mechanisms of
Zta-mediated growth arrest indicate that Zta affects
growth arrest through more than one independent path-
way (Rodriguez et al., 1999 and see above). These stud-
ies have also indicated that the basic/DNA binding re-
gion of Zta is essential for eliciting these growth arrest
activities. Despite the dependence on Zta’s basic/DNA-
binding domain, Zta-mediated growth arrest is largely
independent of Zta’s transactivation function (Cayrol and
Flemington, 1996b; Rodriguez et al., 1999). To further
explore the role of Zta’s basic/DNA-binding domain in
facilitating growth arrest, we generated and analyzed a
FIG. 3. Forced expression of c-myc overrides Zta-mediated growth a
of pGFP-Sp and the indicated amounts of c-myc and Zta-expression pl
hours later, cells were harvested and subjected to FACS analysis to
analysis was performed using the following antibodies: anti-Zta (M47)
anti-p27 (Transduction Laboratories).panel of basic region point mutants [note that wild-type
and mutant Zta constructs contain an in frame nuclearlocalization signal at the carboxyl terminal end of the Zta
reading frame (Flemington et al., 1994)]. As shown in
Figs. 4A and 4B, two previously described DNA binding
mutants, Zdbm1 and Zdbm2 (Flemington et al., 1994),
induce growth arrest, although not as efficiently as wild-
type Zta. As shown in Fig. 4C, a wider panel of more
subtle mutants were also tested. While most mutations
had no apparent effect on growth arrest, two mutants,
Z(I177D) and Z(A185K), had a moderate effect, and one
mutant, Z(S186E), was almost completely defective for
induction of growth arrest. Since Z(A185K) and Z(S186E)
are proximal, these mutations may have related func-
tional effects. Interestingly, although mutation of serine
186 to glutamic acid [i.e., Z(S186E)] has a significant
impact on Zta-induced growth arrest, mutation of this
residue to an alanine has little affect on Zta-mediated
growth arrest (Rodriguez et al., 1999 and Fig. 4). This
suggests the possibility that phosphorylation of this site
may abrogate Zta’s growth arrest function. While this site
is a previously described protein kinase C (PKC) phos-
phorylation site (Baumann et al., 1998), we have been
unable to address whether PKC-mediated phosphoryla-
tion of S186 alters Zta’s growth arrest function because
ela and NPC-KT cells were transfected in 100 mm dishes with 200 ng
[plus 28 mg of the carrier plasmid, pGL3Basic (Promega)]. Forty-eight
ine the cell cycle distribution of the GFP positive cells. Western blot
53 (D01, Santa Cruz Biotech), anti-p21(C19G, Santa Cruz Biotech), andrrest. H
asmids
determactivation of the PKC pathway alone elicits growth arrest
(data not shown).
cell po
La cells
163ROLE OF C-MYC IN ZTA-MEDIATED INDUCTION OF p21 AND p27The mutation series shown in Fig. 4 contained a two
amino acid gap of positions N182 and R183. Analysis of
the solved structure of the Zta homolog, c-Fos (Glover
and Harrison, 1995), suggests that these two residues
are in close proximity to S186 and that they would be on
the same side of the alpha helix. In contrast, V184 would
be predicted to be on the other side of the alpha helix.
Accordingly, a nonconservative mutation of V184 to glu-
FIG. 4. Genetic analysis of Zta basic DNA binding domain. (A) Sche
analysis. (B) Analysis of two previously characterized Zta DNA bind
cotransfected with 2 mg of the indicated control, or Zta expression pla
carrier plasmid, pGL3Basic (Promega)]. GFP positive (i.e., transfected
analysis of basic region mutants. Experiments were carried out in Hetamic acid [i.e., Z(V184E)] has no significant impact on
Zta-mediated growth arrest (Fig. 4). We therefore gener-ated mutations specifically at residues N182 and R183
and assessed the ability of the resulting mutants to
induce growth arrest. As shown in Fig. 5, nonconserva-
tive mutation of each of these residues significantly in-
hibits Zta’s ability to induce growth arrest. Together these
data identify a short interaction surface which likely con-
tacts a factor that is crucial for transducing a Zta-medi-
ated growth arrest signal.
epresentation of basic region mutants and summary of growth arrest
tants, Zdbm1 and Zdbm2 (Flemington et al., 1994). Hela cells were
d 200 ng of the GFP expression plasmid, pGFP-Sp [plus 28 mg of the
pulation) was specifically analyzed by FACS analysis. (C) Cell cycle
as described in B.matic r
ing mu
smid anWe next assayed the ability of these key mutants to
affect the expression of c-myc, p53, p27, and p21. As
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164 RODRIGUEZ ET AL.shown in Fig. 6, Z(S186E), Z(N182E), and Z(R183E) are
impaired for their ability to suppress c-myc expression.
Consistent with a compromised ability to suppress
c-myc expression, Z(S186E), Z(N182E), and Z(R183E) do
not fully induce p21 and p27. Nevertheless, these mu-
tants induced p21 and p27 expression significantly
above background (Cntl), suggesting the possibility that
these factors are also influenced by a c-myc-indepen-
dent pathway. Using stable inducible Zta expressing cell
lines, previous studies (Rodriguez et al., 1999), and ex-
eriments discussed above (Fig. 2), have shown that the
ta basic region mutant, Z/Fos(basic), is defective for
nduction of p21, p27, and down regulation of c-myc. In
ddition, we have observed a complete failure of Z/Fos-
basic) to regulate these factors in transient transfection
xperiments (data not shown). This suggested that an-
ther region of Zta’s basic domain may also influence
hese pathways. Notably, the initial panel of basic region
utants shown in Fig. 4 contained a number of conser-
ative mutations in the carboxyl terminal region of this
FIG. 5. Analysis of residues N182 and R183 in growth arrest function.
HeLa and NPC-KT cells were transfected with pGFP-Sp and the indi-
cated Zta expression vector as described in Fig. 4 legend. Forty-eight
hours later, cells were harvested and FACS analysis was carried out on
the GFP positive population to assess the cell cycle distribution.omain. We therefore generated a new series of mutants
ontaining nonconservative mutations at amino acidsK192, F193, K194, and Q195. All four of these mutants are
fully capable for repressing c-myc expression (Fig. 7).
Nevertheless, Z(K192E) and Z(K194E) showed impaired
growth arrest function and both of these mutants are
compromised for induction of p21 and p27. This further
supports the notion that although Zta-mediated down
regulation of c-myc influences the induction of p21 and
p27, these factors are also regulated by Zta through a
c-myc-independent pathway. In addition, these data
identify a second domain of Zta’s basic region that elicits
growth arrest signaling through a distinct pathway.
DISCUSSION
Accumulating evidence clearly indicates that in direct
contrast to small DNA tumor viruses, herpesviruses have
an evolutionarily conserved preference to replicate in a
FIG. 6. Regulation of c-Myc, p53, p27, and p21 by Zta basic region
point mutants. HeLa cells were transfected with pGFP-Sp and the
indicated Zta expression vector as described in Fig. 4 legend. Forty-
eight hours later, cells were harvested and FACS analysis was carried
out on the GFP positive population to assess the cell cycle distribution.
A fraction of the cells were lysed directly in SDS–PAGE loading dye,
boiled for 20 min, and analyzed for expression of Zta (M47), c-Myc (C33,
Santa Cruz), p53 (D01, Santa Cruz), p27 (anti-p27/Kip1, Transduction
Laboratories), and p21 (anti-p21/Cip1, Transduction Laboratories). This
experiment was carried out independently of the experiment shown in
Fig. 5.
165ROLE OF C-MYC IN ZTA-MEDIATED INDUCTION OF p21 AND p27growth arrested environment. Having the genetic capac-
ity to encode much of the machinery that is required for
efficiently replicating their own genomes, these viruses
have evolved specific mechanisms to help ensure that
viral replication occurs in the absence of competitive
cellular genomic replication. Our previous studies have
shown that in some settings, the EBV-encoded immedi-
ate early gene product, Zta, plays a role in facilitating a
cell growth arrested environment to help enhance viral
genomic replication. These studies have begun to reveal
some of the mechanistic characteristics of Zta-mediated
growth arrest as well as some of the key cellular cell
cycle control factors that are involved in this process.
While viral proteins that induce cell cycle progression
have been extensively studied for a number of years, the
discovery and analysis of viral proteins with cell growth
inhibitory activity is relatively new. Studies from trans-
FIG. 7. Regulation of c-Myc, p53, p27, and p21 by Zta basic region
point mutants. HeLa cells were transfected with pGFP-Sp and the
indicated Zta expression vector as described in Fig. 4 legend. Forty-
eight hours later, cells were harvested and FACS analysis was carried
out on the GFP positive population to assess the cell cycle distribution.
A fraction of the cells were lysed directly in SDS–PAGE loading dye,
boiled for 20 min, and analyzed for expression of Zta (M47), c-Myc (C33,
Santa Cruz), p53 (D01, Santa Cruz), p27 (anti-p27/Kip1, Transduction
Laboratories), and p21 (anti-p21/Cip1, Transduction Laboratories). This
experiment has been repeated with similar results.forming proteins such as adenovirus E1A or SV40 T
antigen have revealed that they directly target multipledistinct cellular cell cycle control proteins (e.g., p300,
CBP, p53, pRB, etc.) and together these interactions help
facilitate activation of cell proliferation (Ludlow and
Skuse, 1995). Although the effects of Zta on cell cycle
regulatory functions are the opposite of E1A and T anti-
gen, Zta similarly carries out its functions through a
complex series of interactions with multiple cell cycle
control proteins (Fig. 8). Specifically, our previous studies
have shown that induction of p21 occurs in part through
a p53-dependent and in part through a p53-independent
pathway. Here we have shown that Zta down regulates
c-myc expression and that although this activity is crucial
for mediating growth arrest (and for fully inducing p21
and p27), another distinct Zta-mediated signaling event
also plays a crucial role in inducing growth arrest and
facilitating maximal p21 and p27 induction (Fig. 8). Fi-
nally, we have also shown here that the Zta-mediated
induction of p53 expression occurs through a c-myc-
independent mechanism.
The results presented here have defined a small re-
gion of the basic/DNA binding domain of Zta that plays a
crucial role in inducing growth arrest (residues NRVAS).
Interestingly, the previously published structure c-Fos/
c-Jun heterodimer (Glover and Harrison, 1995) predicts
that the Zta residues identified here to be crucial for
FIG. 8. Model for Zta-mediated growth arrest. Previous studies (Cay-
rol and Flemington, 1996a) showed that Zta causes hypophosphoryla-
tion of the tumor suppressor protein, pRb, a key target of cyclin/cdks in
cell cycle regulation through induction of the cyclin-dependent kinase
inhibitors, p21 and p27. We show here that Zta mediates down regula-
tion of c-myc expression and that this is essential for high-level p21 and
p27 expression. In addition, however, we provide evidence for an
additional independent mechanism that is essential for efficient growth
arrest and plays a role in modulating p27 and p21 levels. Both the
c-Myc-dependent pathway and the c-Myc-independent pathway re-
quire an intact basic domain of Zta but these two signaling pathways
require distinct subregions (and functions) of this domain.
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166 RODRIGUEZ ET AL.inducing growth arrest, N182, R183, and S186, may be
predominantly positioned away from the DNA helix when
Zta is bound to DNA. This raises the possibility that the
growth arrest function (and the c-myc down regulatory
function) of this region may be elicited through interac-
tions with key cell cycle regulatory proteins and not
through binding to DNA. Although we cannot, at this time,
discount the possible role of DNA binding in influencing
c-myc repression and inducing growth arrest, the Zta
mutant, Zdbm1, which is defective for its ability to bind
DNA, can repress c-myc expression (data not shown).
Interestingly, Baumann et al. have provided evidence that
a cellular factor interacts with this region of Zta when
S186 is phosphorylated, but not when it is not phosphor-
ylated (Baumann et al., 1998). It was also shown that this
interaction likely plays a role in facilitating Zta-mediated
activation of genomic viral gene expression (Baumann et
al., 1998; Francis et al., 1997). In contrast, our studies
uggest that a growth arrest mediator interacts with Zta’s
asic region specifically when serine 186 is not phos-
horylated. Importantly, such a factor(s) would be pre-
icted to have overlapping binding specificity with the
actor identified by Baumann et al. (1998). Whether these
actors are related or distinct, it is likely that these factors
ould compete for binding to this region. Such compe-
ition would then be part of a regulatory mechanism that
licits switching between different Zta functions (i.e.,
ranscriptional activation vs growth arrest).
It is clear that Zta’s basic region is a complex func-
ional domain that not only plays a role in direct DNA
inding but also in multiple protein–protein interactions.
esides the unknown factor identified by Baumann et al.
1998) that interacts specifically with Zta’s basic region
hen S186 is phosphorylated, several other studies have
ither implicated, or directly demonstrated, the binding of
ellular proteins to this region of Zta. Using Zta as a
robe to screen an expression library, Aho et al. (2000)
dentified a ubiquitously expressed factor, referred to as
binuclein, that interacts directly with the basic region of
ta. Although this factor is of unknown function, Aho et al.
2000) found that overexpression of ubinuclein in kera-
inocytes caused morphological changes resembling ter-
inal differentiation. A limited genetic analysis of Zta’s
nteraction with ubinuclein indicated that the second half
f Zta’s basic region is crucial. Moreover, a mutant in
hich K192 and K194 are substituted for alanine resi-
ues was found to be defective for binding to ubinuclein.
e show here that nonconservative mutations in either
192 or K194 decreases Zta-mediated growth arrest and
ompromises Zta’s ability to induce p21 and p27 through
c-myc-independent mechanism. Therefore, it is possi-
le that the interaction between Zta and ubinuclein might
lay a role in influencing p21 and p27 induction and
ta-mediated growth arrest. Further studies will be re-
uired to rigorously address this issue.
NAnother study has shown that Zta’s basic region inter-
acts directly with the TATA box binding factor, TBP (Mi-
kaelian et al., 1993). This study showed that a number of
different Zta basic region mutations inhibited, but did not
abrogate, the binding of TBP. One of these Zta mutants
was the K192 and K194 alanine mutant used in the
ubinuclein study mentioned above. Therefore, it will also
be important to determine whether Zta’s interaction with
TBP might influence Zta-mediated growth arrest.
Other studies have provided indirect evidence that Zta
interacts with chromatin components. Ellwood et al.
(1999) have previously shown that Zta activates tran-
scription cooperatively with high mobility group (HMG)
proteins. This class of proteins generally binds cooper-
atively to DNA and to transcription factors. It is possible
that HMG proteins might make specific interactions with
Zta’s basic region, although this issue has not been
specifically addressed. Interestingly, Zta interacts with
the coactivator, CREB binding protein (CBP) (Adamson
and Kenney, 1999; Zerby et al., 1999) and Chen et al.
(2001) have shown that Zta activates the histone acetyl
transferase (HAT) activity of CBP specifically in the pres-
ence of chromatin. Although the way in which Zta inter-
acts with chromatin in this setting is unclear, Zta might
interact directly with chromatin protein components.
Such interactions could potentially influence global gene
expression patterns which could contribute to gene ex-
pression changes that occur during Zta-mediated cell
growth arrest.
MATERIALS AND METHODS
Cell culture
The generation of stable inducible HeLa (human cer-
vical carcinoma) cell lines has been described previ-
ously (Rodriguez et al., 1999). NPC-KT cells [a hybrid cell
line derived from the fusion of AdAH cells and EBV
genome-positive NPC epithelial explant (Takimoto et al.,
1984)] were a generous gift from Takeshi Sairenji. All cell
lines were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM; Life Technologies), supplemented with
10% fetal bovine serum (Life Technologies). Media for
stable cell lines were also supplemented with 1 mg/ml
etracycline (Sigma) prior to induction.
Transient transfections were performed using a mod-
fied calcium phosphate procedure (for a detailed de-
cription, go to www.flemingtonlab.com). Approximately
0% confluent cultures were split 1/12 onto 100-mm-
iameter tissue culture dishes. The following day, the
edia were replaced with 8 ml of fresh DMEM (110%
BS). Four hours later, DNA precipitates were generated
y mixing 0.5 ml of 13 HEPES-buffered saline [0.5%
EPES, 0.8% NaCl, 0.1% dextrose, 0.01% anhydrous
a2HPO4, 0.37% KCl (pH adjusted to 7.1)] with a total of 30
mg of plasmid DNA (see figure legends for amounts of
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167ROLE OF C-MYC IN ZTA-MEDIATED INDUCTION OF p21 AND p27plasmid DNA added), followed by the addition of 30 ml of
.5 M CaCl2 (samples were mixed immediately following
he addition of CaCl2). Precipitates were allowed to form
at room temperature for 20 min before adding dropwise
to cells. Cells were incubated at 37°C with 5% CO2 for
6 h before the media was replaced with 10 ml of fresh
MEM (110% FBS).
lasmids
Plasmid pUHD10 (Gossen and Bujard, 1992) was used
o generate tetracycline-inducible (Tet-off) expression
lasmids. pUHD10-Zta, -Zta(S186A), and -Zta(129–245)
ere described previously (Rodriguez et al., 1999).
SV40-based Zta expression plasmids used for transient
ransfection experiments were previously described
Flemington and Speck, 1990). For transient transfection
tudies, cells were cotransfected with the green fluores-
ent protein (GFP) expression vector pGFP-Sp (Kalejta et
l., 1997). Site-directed Zta mutant expression vectors
ere generated using the plasmid, pSV40-Zta. Mutants
ere generated as previously described (Foss and Mc-
lain, 1987) and screened by sequencing.
orthern blot analysis
Northern blot experiments were carried out as previ-
usly described (Cayrol and Flemington, 1995). Briefly,
NAs from HeLa and HeLa–Zta cells grown in the pres-
nce or absence of tetracycline were isolated by acid
uanidium isothiocyanate-phenol-chloroform extraction
Chomczynski and Sacci, 1987). RNAs were denatured,
ractionated by electrophoresis through 1% agarose-
ormaldehyde gels, and transferred to nylon membranes
Hybond-N; Amersham). RNAs were cross-linked to the
embranes by UV irradiation. Blots were prehybridized
or 2 h and hybridized with the corresponding probes
vernight at 42°C in 50% formamide, 63 SSC, 0.5% SDS,
53 Denhardt’s solution, 10 mM EDTA (pH 8), 100 mg
almon sperm DNA/ml. Blots were washed with 23 SSC,
.5% SDS at room temperature for 2 min, then with 23
SC, 0.1% SDS for 15 min, and with 0.23 SSC, 0.5% SDS
for 2 h at 55°C. Autoradiography (Kodak XR) was per-
formed at 270°C for 1–3 days.
Western blot analysis
Following trypsinization and neutralization, a fraction
of the harvested cells were washed one time with 13
phosphate buffered saline (PBS). The cell pellet was
quickly suspended in 15 vol of sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) loading
buffer [0.125 M Tris (pH 6.8), 10% glycerol, 2% SDS, 5%
2-mercaptoethanol, 0.05% (w/v) bromphenol blue] and
boiled for 20 min to shear the genomic DNA. Cell lysates
were subjected to SDS–PAGE electrophoresis and trans-
ferred to nitrocellulose membranes. The blots wereblocked for 30 min in 13 Tris-buffered saline plus
TWEEN 20 [TBST, 0.25 mM Tris (pH 7.4), 137 mM NaCl,
2.6 mM KCl, 0.1% TWEEN 20] containing 5% low-fat pow-
dered milk and 3% fetal bovine serum and then incu-
bated with the indicated primary antibody (in blocking
buffer) for either 1 h at room temperature or overnight at
4°C. The blots were washed three times with 13 TBST
(each wash was carried out for approximately 15 min).
The blots were then incubated with peroxidase-conju-
gated secondary antibody in blocking buffer for 1 h at
room temperature. Blots were washed as described
above and analyzed with an enhanced chemilumines-
cence detection system (New England Nuclear) accord-
ing to manufacturer’s recommendations, and filters were
exposed to Kodak XR film. Antibodies used for each
experiment are indicated in their respective figure leg-
ends.
Cell cycle analysis
For cell cycle analysis, cells were collected, washed
once with 13 PBS, suspended in cold (4°C) 0.5 ml of 13
PBS–0.1% glucose, fixed with 5 ml of 70% cold ethanol
(220°C) for at least 45 min (up to 1 week) at 4°C,
washed with 13 PBS, and treated for 30 min at 37°C with
RNase A (0.5 mg/ml) in a 69 mM propidium iodide
(Sigma), 38 mM sodium citrate solution. Cell cycle anal-
ysis was carried out with a fluorescence-activated cell
sorter (FACS) (Becton–Dickinson). Detailed protocols for
all methods can be found at www.flemingtonlab.com.
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